VistaGen Therapeutics, Inc. (VSTA) Human Pluripotent Stem Cell Technology is the Backbone of Promising Development Strategy
Human Clinical Trials in a Test Tube™ -- sounds like something out of a science fiction movie, but as it turns out, this is science reality. VistaGen Therapeutics is the developer of this versatile human pluripotent stem cell (hPSC) technology platform. The hPSC-based bioassay systems more closely approximate human biology than conventional animal testing and other nonclinical techniques currently being used, providing a high-potential path of success to the company’s primary objective. In line with its overarching goal to revive once-promising drug candidates (drug rescue variants) that were abandoned due to unexpected heart or liver safety concerns, VistaGen has used…